June 4, 2010

FDA Committee Unanimously Votes to Approve Tesamorelin (Egrifta) for Lipodystrophy

http://www.hivandhepatitis.com/recent/2010/0604_2010_a.html http://www.poz.com/articles/egrifta_fda_recommends_761_18484.shtml
May 29, 2010

Survey: Most patients with HIV lipodystrophy are willing to inject Egrifta once a day to reduce their visceral fat

 LIPODYSTROPHY TREATMENT- PATIENT ACCEPTANCE DownloadCreate Chart1. Has your belly fat increased after starting HIV medications? answered question 85 skipped question 2 Response Percent Response Count Yes […]
May 28, 2010

Impact of Lipodystrophy on Quality of Life of People Living With HIV- Survey Results

1. How old are you?   answered question 1,325   skipped question 6   ResponsePercent ResponseCount Under 15 years old 0.3% 4 15-20 0.2% 2 20-25 […]
May 28, 2010

FDA Committee Unanimously Recommends Egrifta for Lipodystrophy

FROM POZ.COM May 27, 2010 FDA Committee Unanimously Recommends Egrifta for Lipodystrophy A U.S. Food and Drug Administration (FDA) advisory committee has unanimously recommended that Egrifta […]